Amundi Stoxx Europe Select Dividend 30 UCITS ETF Dist (SELP)

Selkirk Copper Announces Initial Results from the Phase 2 Drill Program and Commencement of Technical Data Collection to Support Planned Feasibility StudyJuly 8, 2026 7:00 AM
Newsfile

Occidental Petroleum Jumps After Evercore Double Upgrade (OXY)July 8, 2026 7:10 AM
IH Market News Occiden

Surge Announces Addition of Cesium-Rubidium To Nevada North Following Averages Of Up To 291ppm Rb And 125ppm Cs In Primary HorizonsJuly 8, 2026 7:00 AM
Newsfile

Occidental Petroleum Jumps After Evercore Double Upgrade (OXY)July 8, 2026 7:10 AM
IH Market News Occiden

Occidental Petroleum Jumps After Evercore Double Upgrade (OXY)July 8, 2026 7:10 AM
IH Market News Occiden

$BABA PT lowered to $180 from $190 at $MS - keeps Overweight rated

$SRCO Sparta's Municipal Finance Program provides financing for municipalities and public agencies seeking to acquire essential-use equipment and related municipal assets through multi-year financing structures rather than outright purchase.
✅The program has supported a wide range of asset c

IMO, lotta peeps are going to be kicking themselves for selling or bashing. The first news leak is that it's installed, and testing has started. What a pop we are going to get! Loaded up for the POP and shares to let it ride!

$SRCO Sparta's Municipal Finance Program provides financing for municipalities and public agencies seeking to acquire essential-use equipment and related municipal assets through multi-year financing structures rather than outright purchase.
✅The program has supported a wide range of asset c

😂😂

Lets keep our eyes peeled for......"NAMSA will initially seek an Investigational Device Exemption (IDE) to organize and conduct a study of UHP's neutralized cellulose hemostat technology?" When is hugely important because the locations for the clinical trials are in place ready for deployment of CE

$PFSA 2.40 added some dips on it, DT showing a float of 530K post split day 2, I guess the Prospectus filed scared some people into selling, typically this low of float doesn't trade this cheap, seems like a good R/R for a nice lotto play.

Oh, the old pumpers morphing this into FDA approval, which they know is years off at best. It wasn't even an IDE approval.

They're authorized to treat "5 patients with non-resectable papillary thyroid carcinoma" with nothing to lose and now have to prove efficacy and safety with thos

WOW.AFTER THE CLOSE YESTERDAYS UPDATE.AND NOISE BY OTHER POSTERS.I SEE A LOT OF LIKES.I GUESS WE ARE NOT THE ONLY ONES ON IHUB LOADING THE BOAT.BUT THE LOWER SHE GOES THE BETTER:))))I WANT CHEAP SHARES.
SO I CAN CALL THE CARDS BRO:))))THE CRYPTO LION SAYS I WILL NOT CALL THE CARDS.HMMMM WE WI

Seablue, if you're strapped for time, listen to the Crux interview I posted. That has more information in it than the webinar IMO.

CLRO starting its climb already

When considering the effect of tariffs, it’s important to remember that Trump is temporary.  He will be out of office in a little more than two years (unless something happens that causes an earlier exit). The decisions he makes on tariffs are even more temporary because he constantly changes his mi

Stepan to Announce Second Quarter 2026 Results on July 29, 2026July 8, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"NORTHBROOK, Ill., class="legendSpanClass"July 8, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its s

Ceva, Inc. Schedules Second Quarter 2026 Earnings Release and Conference CallJuly 8, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"ROCKVILLE, Md., class="legendSpanClass"July 8, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the

PTC to Announce Fiscal Q3'26 Results on Wednesday, July 29, 2026July 8, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"BOSTON, class="legendSpanClass"July 8, 2026 /PRNewswire/ --

We have suffered 15 years with the silence and dilution. When will the company do the right thing for their investors. 

Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar FibromatosisJuly 8, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"DUBLIN, class="legendSpanClass"July 8,